“A new journal is offering something we’ve never seen before: A cash reward to corresponding authors of papers it publishes. Normally, in the case of open-access journals, researchers have to pay article processing charges (APCs). But Minimally Invasive Surgical Oncology, an open-access journal launched at the end of last year, flips the typical narrative — it will pay corresponding authors $500 for every original or review article it accepts. If any author joins the editorial board, the payment — which the journal dubs “royalties” — increases to $600.”
“The increasingly open and transparent nature of academic research is something I’ve touched upon many times on this blog in recent years. Further evidence of this general trend has emerged via the launch of MNI Open Research, a new platform for the publication of neuroscience research.
The platform aims to facilitate open and transparent peer-review, with all of the data used in the studies published, including null results, so that other researchers can avoid duplication, and also test the replicability of research.”
“Addgene is a global, nonprofit repository that was created to help scientists share plasmids. Plasmids are DNA-based research reagents commonly used in the life sciences. When scientists publish research papers, they deposit their associated plasmids at Addgene. Then, when other scientists read the publication, they have easy access to the plasmids needed to conduct future experiments. Before Addgene, scientists were tasked with repeatedly shipping plasmids to each new requesting scientist. Now, scientists ship their plasmids to Addgene once, and we take care of the quality control, MTA compliance, shipping, and record-keeping.
For scientists looking to use plasmids, Addgene provides a searchable database of high-quality plasmids, pooled libraries, and plasmid kits, available at affordable prices. All plasmids in Addgene’s repository are sequenced for quality control purposes and tracked with barcodes from the time they arrive at our facility until they are packed for shipment. Scientists can request plasmids through Addgene’s online ordering system. As of 2016, Addgene also provides ready-to-use AAV and lentivirus preparations of commonly requested plasmids as a service to scientists….”
“Open Therapeutics™ facilitates and enables collaboration among life science researchers around the world!
There are highly qualified scientists everywhere. They want to collaborate. However, there is no comprehensive platform for them to do so – until now!
The Open Therapeutics’ Therapoid™ scientific ecosystem enables much more than just collaboration.
As a web platform for scientific collaboration Therapoid includes:
Open biotechnologies for advancing research and gaining publications,
Funding to further develop open biotechnologies,
An asset exchange that hosts freely available equipment and supplies,
A manuscript development process,
A preprint server for hosting manuscripts.
Goals of Open Therapeutics’ include lowering biotechnology and pharmaceutical costs, reducing the risks and time to develop life-saving therapies, and broadening markets for therapeutics, particularly for underserved populations around the world.”
“Open Therapeutics™ facilitates biopharma developments by enabling capable and responsible researchers around the world to collaborate. Open Therapeutics has two components: (i) an open web platform for scientific collaboration known as Therapoid™, and (ii) open biotechnologies for rapid prototyping of therapeutics.
Open Therapeutics™ enables open access, open collaboration, rapid prototyping, meritocracy, and community. The goal is to lower costs, reduce risks and time, and broaden markets for therapeutics.
The Therapoid™ web portal enables international scientists to share research easily, while it also opens a path to develop dormant technologies. Simple to use tools enable more effective collaboration. The combination of collaboration and biotechnologies will lead to better therapeutics for patients in every country….”
Abstract: As a growing number of biologists formally share their papers in online repositories, it’s often said that they are catching up with physicists, who have posted preprints in the online arXiv server since 1991. But biomedical scientists were actually first, reveals a researcher who has traced a “forgotten experiment” from the 1960s, when the National Institutes of Health (NIH) in Bethesda, Maryland, created a preprint exchange but shut it down when publishers objected. Matthew Cobb, a biologist and science historian at the University of Manchester in the United Kingdom, recounts how starting in 1961, a 70-year-old NIH administrator named Errett Albritton formed what he called information exchange groups, consisting of interested scientists working in the same subfield.
“onthewards is a free open access medical education website dedicated to creating resources for the doctors of today and tomorrow. Our educational topics are selected by junior doctors for junior doctors.
We release a podcast (onthepods) each week that can be listened to directly from the website, downloaded through our app or streamed via iTunes or your favourite podcast service. Each podcast also includes a summary of the content, written by a junior doctor….”
“F1000Research is an Open Research publishing platform offering immediate publication of articles and other research outputs with no editorial bias. All articles benefit from transparent peer review and the inclusion of all source data….The traditional anonymous pre-publication peer review of research articles can cause long delays before new results become visible. F1000Research uses an author-led process, publishing all scientific research within a few days. Open, invited peer review of articles is conducted after publication, focusing on scientific soundness rather than novelty or impact….”
“What are One Mind’s open science principles?
To support Open Science for brain disease and injury, One Mind urges the international research community to adopt the following principles:
Provide informed consents for collection of medical data obtained from patients, which should permit use of their de-identified (anonymous) data for research related to a broad range of conditions — consistent with protecting patient privacy.
Use widely accepted common data elements and conform to the highest possible standards when clinical data is collected. This enables it to be used by the widest possible array of users, whether academic, medical, clinical or commercial.
Make data available to the research community as soon as possible after study completion, with the goal of opening data access within six months whenever possible.
Make data accessible to external researchers during the course of a study (subject to relevant data use agreements).
Give data generators proper attribution & credit from those who use their data.
Do not delay the publication of findings, as it may affect patient care.
Intellectual property should not stand in the way of research, but be used to incentivize material participation….”